Insights speaks directly to the people with an inside track on the big issues. Here, Dan Glass demands drug company Gilead ...

On Thursday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $92.11 which represents a decrease of $-0.52 or -0.56% from the prior close of $92.63. The stock opened at $92.31 and ...

Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, today announced the pricing of senior unsecured ...

George Orwell’s “1984,” about a society under authoritarian control and surveillance, and Ray Bradbury’s book-burning novel “Fahrenheit 451” have also seen a parallel rise in sales. "1984" hit No. 13, ...

“Home” is part of the Robinson’s Gilead-set series. The novel takes place in a remote fictional rural Iowan town in 1956, ...

On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $96.57 which represents a decrease of $-1.33 or -1.36% from the prior close of $97.9. The stock opened at $96.05 and ...

“The Handmaid’s Tale” was popular throughout Trump’s first term, along with such dark futuristic narratives as George ...

"Hispanics voted to deport other Hispanics, white women voted to disempower themselves, their daughters and their daughters’ ...

Gilead Sciences has a Zacks Rank of #2 (Buy), while Vertex Pharmaceuticals has a Zacks Rank of #3 (Hold) right now. Investors should feel comfortable knowing that GILD likely has seen a stronger ...

We have officially kicked off Transgender Awareness Week — which is about to turn into just “Transgender Awareness” come 2025 ...

#TheHandmaidsTale will return Spring 2025." The Handmaid's Tale is based on the book by Margaret Atwood, and is set in a ...

Atwood said she hesitates to make blanket statements about what drives the American people because there are starkly ...